Nutrien Ltd. (NTR)
| Market Cap | 32.57B +17.8% |
| Revenue (ttm) | 27.29B +9.1% |
| Net Income | 2.38B +74.6% |
| EPS | 4.93 +78.3% |
| Shares Out | 477.21M |
| PE Ratio | 13.68 |
| Forward PE | 13.95 |
| Dividend | $2.20 (3.22%) |
| Ex-Dividend Date | Sep 29, 2026 |
| Volume | 1,759,608 |
| Open | 67.99 |
| Previous Close | 67.47 |
| Day's Range | 67.65 - 68.61 |
| 52-Week Range | 53.03 - 85.36 |
| Beta | 1.06 |
| Analysts | Buy |
| Price Target | 76.28 (+11.78%) |
| Earnings Date | Aug 5, 2026 |
About NTR
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment markets crop nutrients, crop protection products, seed, and merchandise, as well as provides agronomic application and financing services and solutions; and produces proprietary products, including proprietary crop nutrient, crop protection, and seed products. The Potash segment includes mining and processing of potash. The Nitrogen segment owns and operates ammonia production facilities that of... [Read more]
Financial Performance
In 2025, Nutrien's revenue was $25.95 billion, an increase of 3.73% compared to the previous year's $25.02 billion. Earnings were $2.27 billion, an increase of 236.35%.
Financial StatementsAnalyst Summary
According to 24 analysts, the average rating for NTR stock is "Buy." The 12-month stock price target is $76.28, which is an increase of 11.78% from the latest price.
News
Nutrien (NTR) Q2 2026 Earnings Call Transcript
Potash sales hit records as automation gains offset phosphate margin pressure.
Nutrien price target lowered to $78 from $81 at Barclays
Barclays lowered the firm’s price target on Nutrien (NTR) to $78 from $81 and keeps an Overweight rating on the shares. Fertilizer companies faced a volatile Q2 but supply/demand trends…
Nutrien price target lowered to $84 from $85 at CIBC
CIBC analyst Hamir Patel lowered the firm’s price target on Nutrien (NTR) to $84 from $85 and keeps an Outperformer rating on the shares. Nutrien remains the firm’s top pick…
Nutrien price target lowered to $76 from $81 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Nutrien (NTR) to $76 from $81 and keeps an Overweight rating on the shares.
Nutrien Q2 Earnings Call Highlights
Nutrien NYSE: NTR reported second-quarter adjusted EBITDA of $2.4 billion and first-half adjusted EBITDA of $3.5 billion, up 6% from a year earlier, as record potash sales volumes, proprietary-product...
Nutrien Ltd (NTR) Stock Down 3.5% but Still Overvalued -- GF Score: 72/100
Nutrien Ltd (NTR) Stock Down 3.5% but Still Overvalued -- GF Score: 72/100
Nutrien Earnings Call Transcript: Q2 2026
Record potash sales and strong proprietary product margins drove H1 2026 growth, with adjusted EBITDA up 6% year-over-year and increased share repurchases. Guidance was raised for potash volumes, capex was reduced, and strategic reviews of key assets are ongoing.
Nutrien Registration statement: Q2 2026
Nutrien filed a registration statement on August 6, 2026, providing details about a securities offering with the SEC.
Nutrien Registration statement: Q2 2026
Nutrien filed a registration statement on August 6, 2026, providing details about a securities offering with the SEC.
Nutrien Slides: Q2 2026
Nutrien has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 6, 2026.
Nutrien Earnings release: Q2 2026
Nutrien released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
33 stocks to bet on foreign markets continuing to beat the S&P 500
Surprisingly, many foreign markets are way ahead of the U.S. in year-to-date performance.
Nutrien Ltd. Q2 Sales Increase
(RTTNews) - Nutrien Ltd. (NTR) released a profit for second quarter of $1.214 billion
Nutrien (NTR) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
Although the revenue and EPS for Nutrien (NTR) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street es...
Nutrien Declares Quarterly Dividend of US$0.55 per Share
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today that its Board of Directors has declared a quarterly dividend of US$0.55 per share payable on October 16, 202...
Nutrien reports Q2 adjusted EPS $2.61, consensus $2.72
Reports Q2 revenue $10.812M, consensus $10.4B. “In the first half of 2026, Nutrien (NTR) delivered record potash sales volumes, strong growth in proprietary products margins and further enhanced the r...
Nutrien Reports Second Quarter 2026 Results
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today its second quarter 2026 results, with net earnings of $1.22 billion ($2.53 diluted net earnings per share). S...
Nutrien Ltd (NTR) Shares Fall 4.5% -- GF Value Says Still Overvalued
Nutrien Ltd (NTR) Shares Fall 4.5% -- GF Value Says Still Overvalued
The Iran war sent investors into fertilizer stocks — but here's the China risk everyone's missing
The fertilizer trade as it relates to the Iran war and the Strait of Hormuz is really three trades pointed in different directions.
Nutrien Ltd (NTR) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 68/100
Nutrien Ltd (NTR) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 68/100
Nutrien upgraded to Outperform from Neutral at BNP Paribas
BNP Paribas analyst David Symonds upgraded Nutrien (NTR) to Outperform from Neutral with an $80 price target The firm is turning positive on the fertilizer pricing, with a relative preference…
Nutrien price target lowered to $81 from $85 at Barclays
Barclays lowered the firm’s price target on Nutrien (NTR) to $81 from $85 and keeps an Overweight rating on the shares. The firm reduced estimates in the agriculture space, citing…
Nutrien price target lowered to $85 from $88 at CIBC
CIBC lowered the firm’s price target on Nutrien (NTR) to $85 from $88 and keeps an Outperformer rating on the shares. Heading into Q2 earnings season, the firm has revised…
Nutrien price target lowered to $78 from $83 at BofA
BofA analyst Matthew DeYoe lowered the firm’s price target on Nutrien (NTR) to $78 from $83 and keeps a Buy rating on the shares. The firm is adjusting estimates to…
Nutrien Announces Release Dates for Second Quarter 2026 Results and Conference Call
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Nutrien Ltd. (TSX and NYSE: NTR) announced today plans to release second quarter 2026 results after market close on Wednesday, August 5. Nutrien will host a c...